In G93A-SOD1 mice and ALS patients, miR-206 is up-regulated during disease progression, likely as a compensatory mechanism, albeit not sufficient to counteract neurodegeneration [56,57]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.